843 results on '"Gruslin A"'
Search Results
302. SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro
- Author
-
Du, Meirong, primary, Qiu, Qing, additional, Gruslin, Andree, additional, Gordon, John, additional, He, Miao, additional, Chan, Chi Chung, additional, Li, Dajin, additional, and Tsang, Benjamin K., additional
- Published
- 2013
- Full Text
- View/download PDF
303. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.
- Author
-
Benton, Samantha J., McCowan, Lesley M., Heazell, Alexander E.P., Grynspan, David, Hutcheon, Jennifer A., Senger, Christof, Burke, Orlaith, Chan, Yuen, Harding, Jane E., Yockell-Lelièvre, Julien, Hu, Yuxiang, Chappell, Lucy C., Griffin, Melanie J., Shennan, Andrew H., Magee, Laura A., Gruslin, Andrée, and von Dadelszen, Peter
- Subjects
COMPARATIVE studies ,DELIVERY (Obstetrics) ,FETAL growth retardation ,FETAL malnutrition ,FETAL ultrasonic imaging ,RESEARCH methodology ,MEDICAL cooperation ,PLACENTA ,RESEARCH ,EVALUATION research ,DIAGNOSIS - Abstract
Introduction: Discriminating between placentally-mediated fetal growth restriction and constitutionally-small fetuses is a challenge in obstetric practice. Placental growth factor (PlGF), measurable in the maternal circulation, may have this discriminatory capacity.Methods: Plasma PlGF was measured in women presenting with suspected fetal growth restriction (FGR; ultrasound fetal abdominal circumference <10th percentile for gestational age) at sites in Canada, New Zealand and the United Kingdom. When available, placenta tissue underwent histopathological examination for lesions indicating placental dysfunction, blinded to PlGF and clinical outcome. Lesions were evaluated according to pre-specified severity criteria and an overall severity grade was assigned (0-3, absent to severe). Low PlGF (concentration <5th percentile for gestational age) to identify placental FGR (severity grade≥2) was assessed and compared with routine parameters for fetal assessment. For all cases, the relationship between PlGF and the sampling-to-delivery interval was determined.Results: Low PlGF identified placental FGR with an area under the receiver-operator characteristic curve of 0.96 [95% CI 0.93-0.98], 98.2% [95% CI 90.5-99.9] sensitivity and 75.1% [95% CI 67.6-81.7] specificity. Negative and positive predictive values were 99.2% [95% CI 95.4-99.9] and 58.5% [95% CI 47.9-68.6], respectively. Low PlGF outperformed gestational age, abdominal circumference and umbilical artery resistance index in predicting placental FGR. Very low PlGF (<12 pg/mL) was associated with shorter sampling-to-delivery intervals than normal PlGF (13 vs. 29.5 days, P < 0.0001).Discussion: Low PlGF identifies small fetuses with significant underlying placental pathology and is a promising tool for antenatal discrimination of FGR from fetuses who are constitutionally-small. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
304. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
- Author
-
Magee, LA, Dadelszen, P, Singer, J, Lee, T, Rey, E, Ross, S, Asztalos, E, Murphy, KE, Menzies, J, Sanchez, J, Gafni, A, Gruslin, A, Helewa, M, Hutton, E, Koren, G, Lee, SK, Logan, AG, Ganzevoort, JW, Welch, R, and Thornton, JG
- Subjects
CARDIOVASCULAR disease prevention ,HYPERTENSION ,PREGNANCY complications ,RANDOMIZED controlled trials ,LABETALOL ,ANTIHYPERTENSIVE agents ,METHYLDOPA ,THERAPEUTICS ,LOW birth weight ,BLOOD pressure ,CARDIOVASCULAR diseases in pregnancy ,COMPARATIVE studies ,HYPERTENSION in pregnancy ,PREMATURE infants ,RESEARCH methodology ,MEDICAL cooperation ,PREECLAMPSIA ,PRENATAL care ,RESEARCH ,EVALUATION research ,TREATMENT effectiveness - Abstract
Objective: To determine whether the difference in outcomes between 'less tight' (target diastolic blood pressure [dBP] of 100 mmHg) versus 'tight' control (target dBP of 85 mmHg) in the CHIPS Trial (ISRCTN 71416914, http://pre-empt.cfri.ca/;CHIPS) depended on the choice of labetalol or methyldopa, the two most commonly used antihypertensive agents in CHIPS.Design: Secondary analysis of CHIPS Trial data.Setting: International multicentre randomised controlled trial (94 sites, 15 countries).Population or Sample: A total of 987 women with non-severe non-proteinuric pregnancy hypertension.Methods: Logistic regression was used for comparisons of 'less tight' versus 'tight' control among women treated with labetalol (but not methydopa) versus methyldopa (but not labetalol). Analyses were adjusted for the influence of baseline factors, including use of any antihypertensive therapy at randomisation.Main Outcome Measures: Main CHIPS Trial outcomes: primary (perinatal loss or high-level neonatal care for > 48 hours), secondary (serious maternal complications), birthweight < 10th centile, severe maternal hypertension, pre-eclampsia, and delivery at < 34 or < 37 weeks.Results: Of 987 women in CHIPS, antihypertensive therapy was taken by 566 women at randomisation (labetalol 111 ['less tight'] versus 127 ['tight'] or methyldopa 126 ['less tight'] versus 117 ['tight']) and 815 women after randomisation (labetalol 186 ['less tight'] versus 247 ['tight'] and methyldopa by 98 ['less tight'] versus 126 ['tight']). Following adjustment, odds ratios for outcomes in 'less tight' versus 'tight' control were similar between antihypertensive groups according to 'at randomisation' and 'after randomisation' therapy.Conclusion: Outcomes for 'less tight' versus 'tight' control were not dependent on use of methyldopa or labetalol.Tweetable Abstract: In the CHIPS Trial, maternal and infant outcomes were not dependent on use of labetalol or methyldopa. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
305. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
- Author
-
Magee, LA, Dadelszen, P, Singer, J, Lee, T, Rey, E, Ross, S, Asztalos, E, Murphy, KE, Menzies, J, Sanchez, J, Gafni, A, Gruslin, A, Helewa, M, Hutton, E, Koren, G, Lee, SK, Logan, AG, Ganzevoort, JW, Welch, R, and Thornton, JG
- Subjects
LABETALOL ,METHYLDOPA ,PREGNANCY complications ,HYPERTENSION risk factors ,PRENATAL care ,RANDOMIZED controlled trials ,THERAPEUTICS ,ANTIHYPERTENSIVE agents ,LOW birth weight ,BLOOD pressure ,CARDIOVASCULAR diseases in pregnancy ,HYPERTENSION ,EVALUATION of medical care ,HYPERTENSION in pregnancy ,PREECLAMPSIA ,PREGNANCY ,PREVENTION - Abstract
Objective: To compare pregnancy outcomes, accounting for allocated group, between methyldopa-treated and labetalol-treated women in the CHIPS Trial (ISRCTN 71416914) of 'less tight' versus 'tight' control of pregnancy hypertension.Design: Secondary analysis of CHIPS Trial cohort.Setting: International randomised controlled trial (94 sites, 15 countries).Population or Sample: Of 987 CHIPS recruits, 481/566 (85.0%) women treated with antihypertensive therapy at randomisation. Of 981 (99.4%) women followed to delivery, 656/745 (88.1%) treated postrandomisation.Methods: Logistic regression to compare outcomes among women who took methyldopa or labetalol, adjusted for the influence of baseline factors.Main Outcome Measures: CHIPS primary (perinatal loss or high level neonatal care for >48 hours) and secondary (serious maternal complications) outcomes, birthweight <10th centile, severe maternal hypertension, pre-eclampsia and delivery at <34 or <37 weeks.Results: Methyldopa and labetalol were used commonly at randomisation (243/987, 24.6% and 238/987, 24.6%, respectively) and post-randomisation (224/981, 22.8% and 433/981, 44.1%, respectively). Following adjusted analyses, methyldopa (versus labetalol) at randomisation was associated with fewer babies with birthweight <10th centile [adjusted odds ratio (aOR) 0.48; 95% CI 0.20-0.87]. Methyldopa (versus labetalol) postrandomisation was associated with fewer CHIPS primary outcomes (aOR 0.64; 95% CI 0.40-1.00), birthweight <10th centile (aOR 0.54; 95% CI 0.32-0.92), severe hypertension (aOR 0.51; 95% CI 0.31-0.83), pre-eclampsia (aOR 0.55; 95% CI 0.36-0.85), and delivery at <34 weeks (aOR 0.53; 95% CI 0.29-0.96) or <37 weeks (aOR 0.55; 95% CI 0.35-0.85).Conclusion: These nonrandomised comparisons are subject to residual confounding, but women treated with methyldopa (versus labetalol), particularly those with pre-existing hypertension, may have had better outcomes.Tweetable Abstract: There was no evidence that women treated with methyldopa versus labetalol had worse outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
306. Intrapericardial teratoma in a twin fetus: diagnosis and management
- Author
-
Victor Lucas, Andree Gruslin-Giroux, Mark Sklansky, and Mark T. Greenberg
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Hydrops Fetalis ,Pericardial effusion ,Pericardial Effusion ,Ultrasonography, Prenatal ,Heart Neoplasms ,Pregnancy ,Cardiac tamponade ,Hydrops fetalis ,Diseases in Twins ,Medicine ,Pericardium ,Humans ,Twin Pregnancy ,business.industry ,Obstetrics ,Infant, Newborn ,Teratoma ,Obstetrics and Gynecology ,medicine.disease ,Surgery ,Fetal Diseases ,medicine.anatomical_structure ,Pericardiocentesis ,Pericardiectomy ,Pregnancy Trimester, Second ,Female ,Tamponade ,business - Abstract
Background : A rare cause of hydrops fetalis, intrapericardial teratoma is invariably associated with a pericardial effusion. In fetal life, the effusion or mass effect may cause cardiac tamponade, hydrops, and death. After delivery, ventilation and cardiac output may be compromised. Case : One fetus of twins was diagnosed at 20 weeks' gestation with an intrapericardial teratoma. The affected twin underwent two intrauterine pericardiocenteses and had the tumor resected after delivery at 35 weeks' gestation. One year later, both twins are alive and well and have no evidence of tumor recurrence. Conclusion : Pericardiocentesis for tamponade secondary to a fetal intrapericardial teratoma, even when complicating a twin pregnancy, may prevent fetal death and allow delay of delivery until adequate fetal lung maturity has been achieved.
- Published
- 1997
307. Influence of an educational program on medical students' attitudes to substance use disorders in pregnancy.
- Author
-
Bland, Elaine, Oppenheimer, Lawrence W., Oppenheimer, Lawrence, Brisson-Carroll, Gisèle, Morel, Chantal, Holmes, Paul, Gruslin, Andrée, Bland, E, Oppenheimer, L, Brisson-Carroll, G, Morel, C, Holmes, P, and Gruslin, A
- Subjects
SUBSTANCE abuse ,VICTIMLESS crimes ,ASSESSMENT of education ,HEALTH occupations students ,MEDICAL students - Abstract
Substance use disorders (SUDs) in pregnancy are becoming increasingly prevalent. Our study aimed to measure the effect of a teaching module on alcohol, tobacco, and drug use on the attitude of second year medical students toward pregnant women with SUDs. A questionnaire was administered to 84 medical students before a 5-week systems block on human reproduction, which included specific learning events related to SUDs. The questionnaire was readministered at the completion of the block. Pre- and postintervention scores were compared. Students showed significant improvement (p < .05, reliability coefficient 0.90) in their level of comfort in dealing with womenwith SUD in pregnancy. Other positive trends relating to attitudes toward drug- and alcohol-dependent women during pregnancy were also identified. SUD teaching interventions among medical students can improve their comfort level and attitude toward pregnant women with SUDs. This supports the current initiative of Project CREATE (Curriculum Renewal and Evaluation of Addiction Training and Education) to implement a comprehensive undergraduate SUD teaching program in Canadian medical schools. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
308. Characterization of IGF-II Isoforms in Binge Eating Disorder and Its Group Psychological Treatment
- Author
-
Qing Qiu, Julien Yockell Lelievre, John I. Little, Andrée Gruslin, Hany Bissada, Kerri Ritchie, Livia Chyurlia, Giorgio A. Tasca, Anne Trinneer, and Ann Barber
- Subjects
medicine.medical_specialty ,Epidemiology ,Cross-sectional study ,medicine.medical_treatment ,Population ,lcsh:Medicine ,Physiology ,030209 endocrinology & metabolism ,Overweight ,Biology ,Social and Behavioral Sciences ,03 medical and health sciences ,Endocrinology ,0302 clinical medicine ,Insulin-Like Growth Factor II ,Binge-eating disorder ,Internal medicine ,medicine ,Psychology ,Protein Isoforms ,Obesity ,lcsh:Science ,education ,Nutrition ,030304 developmental biology ,Behavior ,0303 health sciences ,education.field_of_study ,Multidisciplinary ,Population Biology ,Binge eating ,lcsh:R ,medicine.disease ,3. Good health ,Psychotherapy ,Cognitive behavioral therapy ,Biomarker Epidemiology ,Mental Health ,Cross-Sectional Studies ,Interpersonal psychotherapy ,Medicine ,Women's Health ,lcsh:Q ,medicine.symptom ,Binge-Eating Disorder ,Research Article - Abstract
INTRO Binge eating disorder (BED) affects 3.5% of the population and is characterized by binge eating for at least 2 days a week for 6 months. Treatment options include cognitive behavioral therapy, interpersonal psychotherapy, and pharmacotherapy which are associated with varied success. Little is known about the biology of BED. Since there is evidence that the insulin like growth factor system is implicated in regulation of body weight, insulin sensitivity and feeding behavior, we speculated it may be involved in BED. METHODS A cross-sectional comparison was made between three groups of women: overweight with BED, overweight without BED and normal weight without BED. Women were assigned to Group Psychodynamic Interpersonal Psychotherapy. Blood was collected before therapy, at completion and at 6 months follow up for evaluation of IGF-II using Western blot. RESULTS 97 overweight women with BED contributed to the cross-sectional comparison. The two control groups comprised 53 overweight women without BED, and 50 age matched normal weight women without BED. Obese women had significantly lower Big IGF-II than normal weight women, p = .028; Overweight women with BED had higher Mature IGF-II than normal weight women, p
- Published
- 2013
- Full Text
- View/download PDF
309. Excessive gestational weight gain and obesity contribute to altered expression of maternal insulin-like growth factor binding protein-3
- Author
-
Qing Qiu, Zachary M. Ferraro, Andrée Gruslin, and Kristi B. Adamo
- Subjects
medicine.medical_specialty ,International Journal of Women's Health ,Bioinformatics ,Insulin-like growth factor-binding protein ,Insulin resistance ,insulin-like growth factors ,Internal medicine ,Maternity and Midwifery ,medicine ,insulin sensitivity ,Original Research ,Pregnancy ,biology ,business.industry ,insulin-like growth factor binding protein-3 ,Leptin ,Obstetrics and Gynecology ,Gestational age ,medicine.disease ,Obesity ,Endocrinology ,Oncology ,Cord blood ,gestational weight gain ,biology.protein ,pregnancy ,medicine.symptom ,business ,Weight gain - Abstract
Zachary M Ferraro,1 Qing Qiu,2 Andrée Gruslin,3,4 Kristi B Adamo1,3,5 1Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada; 2The Ottawa Hospital Research Institute, Ottawa, ON, Canada; 3Faculty of Health Sciences, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada; 4Departments of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada; 5Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada Background: Excessive gestational weight gain (GWG) increases risk of large for gestational age neonates and subsequent tracking of excess weight throughout the life course for both mother and child. Although the physiological mechanisms underlying these associations are incomplete, the insulin-like growth factor (IGF) axis has garnered attention for its role in fetal growth and development. Our purpose was to characterize the IGF axis protein expression patterns in mother–infant dyads in respect of excessive GWG. Methods: We obtained fasting serum samples and corresponding cord blood from eight controls (ADHERE group: ie, those who gained in accordance with 2009 Institute of Medicine GWG recommendations) and 13 exceeders (EXCEED group: ie, those who exceeded Institute of Medicine GWG recommendations). At study completion, we examined protein expression of IGF-I, IGF-II, IGF binding protein (IGFBP)-1, IGFBP-3, IGFBP-4, and hormone concentrations in both maternal and cord blood. Results: Between-group comparisons were made and revealed elevated maternal leptin (P ≤ 0.05) concentrations in gravidas who exceeded recommendations. There was a significantly higher number of obese women in the EXCEED group (P < 0.05). After adjustment, maternal leptin levels were positively correlated with maternal homeostasis model of assessment for insulin resistance score and excessive GWG (P ≤ 0.01). However, serum IGFBP-3 expression in the EXCEED mothers was greater than that in the ADHERE group (P ≤ 0.05). Conclusion: These findings provide preliminary evidence suggesting that small deviations in IGFBP-regulated IGF bioavailability arising from excessive GWG/positive energy balance may affect adipocyte differentiation through subclinical insulin resistance. Keywords: gestational weight gain, insulin-like growth factors, insulin-like growth factor binding protein-3, pregnancy, insulin sensitivity
- Published
- 2013
- Full Text
- View/download PDF
310. First trimester maternal circulating levels of pregnancy-associated plasma protein A2 (PAPP-A2) are elevated in pregnancies that subsequently develop preeclampsia
- Author
-
Julian K. Christians, Andrée Gruslin, Ursula Durland, Erin J. Crosley, Scott MacRae, and Ken Seethram
- Subjects
Andrology ,First trimester ,Pregnancy ,Reproductive Medicine ,business.industry ,medicine ,Obstetrics and Gynecology ,medicine.disease ,business ,Blood proteins ,Developmental Biology ,Preeclampsia - Published
- 2013
- Full Text
- View/download PDF
311. Maternal serum levels of FGL2 as screening tool for preeclampsia
- Author
-
Julien Yockell-Lelièvre, Barbara C. Vanderhyden, and Andrée Gruslin
- Subjects
medicine.medical_specialty ,Fetus ,Obstetrics ,business.industry ,education ,Obstetrics and Gynecology ,medicine.disease ,Molecular medicine ,humanities ,FGL2 ,Preeclampsia ,medicine.anatomical_structure ,Reproductive Medicine ,Obstetrics and gynaecology ,Placenta ,medicine ,medicine.symptom ,business ,Pathological ,Vasoconstriction ,Developmental Biology - Abstract
s / Placenta 34 (2013) A1–A99 A41 Conclusion: Free HbF causes acute vasoconstriction of the fetoplacental vasculature by binding NO and disrupting placental endothelial morphology. HbF levels in fetal blood warrant further investigation in normal and pathological pregnancies. http://dx.doi.org/10.1016/j.placenta.2013.06.121 P1.85. ABSTRACT WITHDRAWN HTTP://DX.DOI.ORG/10.1016/J.PLACENTA.2013.06.122 P1.86. MATERNAL SERUM LEVELS OF FGL2 AS SCREENING TOOL FOR PREECLAMPSIA Julien Yockell-Lelievre , Barbara Vanderhyden , Andree Gruslin 1,3 Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Obstetrics and Gynecology, The Ottawa Hospital
- Published
- 2013
- Full Text
- View/download PDF
312. Porous media flow models for maternal placental circulation
- Author
-
Christopher Ball, David Grynspan, and Andrée Gruslin
- Subjects
Placental growth factor ,Fetus ,medicine.medical_specialty ,Placental Circulation ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Chorionic vessels ,Umbilical artery ,Umbilical cord ,humanities ,medicine.anatomical_structure ,Reproductive Medicine ,Obstetrics and gynaecology ,medicine.artery ,Placenta ,Medicine ,business ,Developmental Biology - Abstract
s / Placenta 34 (2013) A1–A99 A15 Conclusion: Detailed placental measures collected by simple imaging methods illuminate placental functional efficiency, a key factor in gestational life that is likely important in fetal programming. PCA demonstrates the complex interactions between lateral expansion of the chorionic plate surface, branching growth of chorionic surface vessels, and arborisation of the fetal stem villi to create the placental surface exchange area that makes up disk thickness. Measurement of any single dimension can lead to misleading conclusions because in different combinations, specific measures may have opposite effects on beta. http://dx.doi.org/10.1016/j.placenta.2013.06.044 P1.8. POROUS MEDIA FLOW MODELS FOR MATERNAL PLACENTAL CIRCULATION Christopher Ball , David Grynspan , Andree Gruslin 3,4 Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada; Department of Pathology and Laboratory Medicine, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; Department of Obstetrics and Gynecology, The Ottawa Hospital, Ottawa, Ontario, Canada; Department of Cellular Molecular Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada Introduction: It is reasonable to believe that the presence of abnormal flow patterns in the chorionic vessels is an earlier and more sensitive predictor of IUGR than altered end diastolic flow in the umbilical artery. It furthermore appears that the prediction of IUGR becomes increasingly sensitive as predictive flowmeasurements are taken increasingly distal (to the fetus) in the umbilical cord. This, we hypothesize, results from remodelling of the villous circulatory beddthe most proximate correlate of the factors that lead to IUGR. The effect of lacunar blood flow, the intimately connected maternal side of placental flow, cannot be ignored. Aim:Our aim is tomodel the fluidmechanics of the normalmaternal lacunar blood flows in order to assess its influence on flow within the measurable parts of the fetal arterial tree. In view of the placental structure, we aim to apply a model of flow through porous media to the maternal flow bed. Methods: Preliminary inquiry has lead us to suspect that this flowproblem is analogous to the problem of laminar flow through a porous medium (such as in models of fuel cells, ground water, etc.). Here we will illustrate application of this canonical flow model to that of the maternal placenta. Discussion: The problem of modelling EDFR provides an example where interdisciplinary collaboration between medicine and engineering hopefully will permit rapid progress through novel application to one field of established constructs from another. http://dx.doi.org/10.1016/j.placenta.2013.06.045 P1.9. ECHOCARDIOGRAPHIC ANALYSES OF PREGNANCIES IN THE PLACENTAL GROWTH FACTOR KNOCKOUT MOUSE Kristiina Aasa , Bruno Zavan , Philip Wong , Yat Tse , Stephen Pang , B. Anne Croy 1 Queen's University, Kingston, ON, Canada; UNIFAL-MG, Alfenas, Minas
- Published
- 2013
- Full Text
- View/download PDF
313. Novel investigation of the importance of Ste20-like kinase, SLK, in murine placentation
- Author
-
Luc A. Sabourin, Prabhjot Sekhon, Daniel R. Tessier, Andrée Gruslin, Julien Yockell-Lelièvre, and Khalid N. Al-Zahrani
- Subjects
Reproductive Medicine ,Immunology ,Obstetrics and Gynecology ,Placentation ,Biology ,STE20 like kinase ,Developmental Biology ,Cell biology - Published
- 2013
- Full Text
- View/download PDF
314. Obesity and Fetal Programming: How Important Is 9 Months Anyway?
- Author
-
Helena Piccinini-Vallis, Laura Gaudet, Zachary M. Ferraro, Andrée Gruslin, Christian F. Rueda-Clausen, Rhonda C. Bell, and Kristi B. Adamo
- Subjects
Pediatrics ,medicine.medical_specialty ,Endocrinology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,medicine ,General Medicine ,Fetal programming ,medicine.disease ,business ,Obesity - Published
- 2013
- Full Text
- View/download PDF
315. The Characterization of Fatty Acid Transport Protein 4 in Third Trimester Placentas from Lean and Obese Pregnancies
- Author
-
Zachary M. Ferraro, Andrée Gruslin, Daniel Tessier, Kristi B. Adamo, and Kendra E. Brett
- Subjects
chemistry.chemical_classification ,medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,Fatty acid ,General Medicine ,Third trimester ,Transport protein ,Endocrinology ,chemistry ,Internal medicine ,Internal Medicine ,Medicine ,business - Published
- 2013
- Full Text
- View/download PDF
316. Maternal Obesity and Excessive Gestational Weight Gain Alter the Maternal-Fetal Insulin-Like Growth Factor Axis
- Author
-
Zachary M. Ferraro, Andrée Gruslin, Qing Qiu, and Kristi B. Adamo
- Subjects
medicine.medical_specialty ,Food intake ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Dietary intake ,General Medicine ,medicine.disease ,Obesity ,Insulin-like growth factor ,Endocrinology ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,Gestation ,Maternal fetal ,medicine.symptom ,business ,Weight gain - Abstract
s / Can J Diabetes 37 (2013) S217eS289 S267 rate variability; the ratio of lowto high-frequency power (LF/HF) reflects the balance between sympathetic and parasympathetic predominance. Participants completed questionnaires on food intake and physical activity. The associations between PEMCS and outcomes were tested with ANCOVA, including sex, age, height, maternal education, gestation length, breast-feeding and birthweight in the model as covariates. Results: Exposed (E; n1⁄4335) vs. non-exposed (NE) had greater visceraland subcutaneous-abdominal fat and total body fat (P1⁄40.01, 0.001 and 0.007, respectively). E vs. NE did not differ in physical activity, but had lower LF/HF (P1⁄40.009) and greater % fat dietary intake (P1⁄4 0.007). Discussion: In adolescence, PEMCS is associated with parasympathetic predominance and higher dietary fat intake. As parasympathetic predominance reduces energy expenditure and excess fat intake increases energy intake, these two factors may be mechanisms by which PEMCS contributes to increased adiposity.
- Published
- 2013
- Full Text
- View/download PDF
317. Maternal Obesity and Excessive Weight Gain Augment Expression of Maternal Insulin-Like Growth Factor Binding Protein-3
- Author
-
Zachary M. Ferraro, Andrée Gruslin, Kristi B. Adamo, and Qing Qiu
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Endocrinology, Diabetes and Metabolism ,General Medicine ,medicine.disease ,Obesity ,Insulin-like growth factor-binding protein ,Endocrinology ,Excessive weight gain ,Internal medicine ,Internal Medicine ,biology.protein ,medicine ,Augment ,business - Published
- 2013
- Full Text
- View/download PDF
318. Maternal Lipid Metabolism Correlates With Surrogate Markers of Insulin-Like Growth Factor Bioavailability in Maternal and Umbilical Cord Serum
- Author
-
Zachary M. Ferraro, Andrée Gruslin, Kendra E. Brett, and Kristi B. Adamo
- Subjects
medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Lipid metabolism ,General Medicine ,Bioavailability ,Insulin-like growth factor ,Endocrinology ,Internal medicine ,Immunology ,Internal Medicine ,medicine ,business ,Umbilical Cord Serum - Published
- 2013
- Full Text
- View/download PDF
319. SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro
- Author
-
Miao He, Andrée Gruslin, Chi Chung Chan, Qing Qiu, Da-Jin Li, John R. Gordon, Benjamin K. Tsang, and Meirong Du
- Subjects
Cell division ,Chemokine CXCL1 ,Tumor Physiology ,lcsh:Medicine ,Apoptosis ,Receptors, Interleukin-8B ,0302 clinical medicine ,Molecular Cell Biology ,Basic Cancer Research ,Signaling in Cellular Processes ,lcsh:Science ,Mitotic catastrophe ,Apoptotic Signaling Cascade ,Apoptotic Signaling ,Ovarian Neoplasms ,0303 health sciences ,Multidisciplinary ,Cell Death ,biology ,Obstetrics and Gynecology ,Transfection ,Cell cycle ,Signaling Cascades ,Ovarian Cancer ,3. Good health ,Cell biology ,Oncology ,030220 oncology & carcinogenesis ,Medicine ,Female ,Research Article ,Signal Transduction ,DNA, Complementary ,Mitosis ,Antineoplastic Agents ,Real-Time Polymerase Chain Reaction ,03 medical and health sciences ,Cyclin-dependent kinase ,Cell Line, Tumor ,Humans ,Biology ,DNA Primers ,030304 developmental biology ,Base Sequence ,Phenylurea Compounds ,Interleukin-8 ,lcsh:R ,Gynecologic Cancers ,Cancers and Neoplasms ,Drug Resistance, Neoplasm ,Cell culture ,biology.protein ,lcsh:Q ,Tumor Suppressor Protein p53 ,Gynecological Tumors ,DNA Damage - Abstract
Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist SB225002 induces apoptosis in Wilms’ tumor cells. Here, we investigated the effect of SB225002 on cell cycle progression and apoptosis induction in vitro, using CDDP-sensitive and -resistant OVCA cell lines with different p53 status (wild type, mutant or null). Adenovirus infection of wild-type p53 or transfection of p53 siRNA was used to over-express or knock-down p53. Cell cycle and apoptosis were determined by flow cytometry or Hoechst staining and observation of nuclear morphology. Our data demonstrated that SB225002 induced apoptosis in both wild-type and p53-deficient ovarian cancer (OVCA) cells through alternative mechanisms. SB225002 promoted mitotic catastrophe, as evidenced by the accumulation of mitotic cells with spindle abnormalities, chromosome mis-segregation, multi-polar cell division, multiple nuclei, aneuploidy/polyploidy and subsequent extensive apoptosis. SB225002-induced mitotic catastrophe appeared to be mediated by down-regulation of checkpoint kinase Chk1 and Cdk1-cyclin B activation. In cells expressing wild-type p53 (OV2008 and C13*), SB225002 increased total and phospho-Ser p53 levels, and p53 knock-down decreased SB225002-induced apoptosis, without affecting premature mitosis. These results suggest that SB225002 induces p53-dependent apoptosis, and provokes mitotic catastrophe in p53-independent manner in p53 wild-type cells. Reconstitution with wild-type P53 in P53-null SKOV3 cell attenuated SB225002-induced mitotic catastrophe, suggesting p53 prevented mitotic catastrophe induced by SB225002 in p53-deficient OVCA cells. Finally, the effect of SB225002 could not be prevented by pretreatment with CXCR2 ligand or its neutralizing antibody. The present studies demonstrate for the first time that SB225002 has dual actions in OVCA cells, inducing classic apoptosis through p53 activation and provoking mitotic catastrophe in both p53 wild-type and deficient cells by Chk1 inhibition and Cdk activation. These findings raise the possibility of SB225002 as a new candidate molecule for OVCA therapy independent of the p53 status.
- Published
- 2013
- Full Text
- View/download PDF
320. Characterization of the holographic imaging grating of GOMOS UVIS spectrometer
- Author
-
Francis Bonnemason, Jussi Graeffe, Heikki Saari, Lorand Mazuray, Jean-Herve Lecat, Kari Rainio, Michel Gruslin, Jean Flamand, Dominique Pierot, Pierre Craen, Heikki Astola, and Alain Thevenon
- Subjects
Physics ,Spectrometer ,Holographic grating ,business.industry ,Optical engineering ,Imaging spectrometer ,Holography ,Grating ,law.invention ,Cardinal point ,Optics ,law ,business ,Diffraction grating ,Remote sensing - Abstract
A Finnish-French group has proposed an imaging spectrometer- based instrument for the ENVISAT Earth observation satellite of ESA, which yields a global mapping of the vertical profile of ozone and other related atmospheric gases. The GOMOS instrument works by measuring the UV-visible spectrum of a star that is occulting behind the Earth's atmosphere. The prime contractor of GOMOS is Matra Marconi Space France. The focal plane optics are designed and manufactured by Spacebel Instrumentation S.A. and the holographic grating by Jobin-Yvon. VTT Automation, Measurement Technology has participated in the GOMOS studies since 1989 and is presently responsible for the verification tests of the imaging quality and opto-mechanical interfaces of the holographic imaging grating of GOMOS. The UVIS spectrometer of GOMOS consists of a holographic, aberration corrected grating and of a CCD detector. The alignment of the holographic grating needs as an input very accurate knowledge of the mechanical interfaces. VTT Automation has designed, built and tested a characterization system for the holographic grating. This system combines the accurate optical imaging measurements with the absolute knowledge of the geometrical parameters at the accuracy of plus or minus 10 micrometers which makes the system unique. The developed system has been used for two breadboard gratings and the qualification model grating. The imaging quality results and their analysis together with alignment procedure utilizing of the knowledge of mechanical interfaces is described.© (1996) COPYRIGHT SPIE--The International Society for Optical Engineering. Downloading of the abstract is permitted for personal use only.
- Published
- 1996
- Full Text
- View/download PDF
321. Characterization of the holographic imaging grating of GOMOS UVIS spectrometer
- Author
-
Graeffe, Jussi, Saari, Heikki, Astola, Heikki, Rainio, Kari, Mazuray, Lorand, Pierot, Dominique, Craen, Pierre, Gruslin, Michel, Lecat, Jean-Herve, Bonnemason, Francis, Flamand, Jean, Thevenon, Alain, Fischer, Robert E., and Smith, Warren J.
- Abstract
A Finnish-French group has proposed an imaging spectrometer- based instrument for the ENVISAT Earth observation satellite of ESA, which yields a global mapping of the vertical profile of ozone and other related atmospheric gases. The GOMOS instrument works by measuring the UV-visible spectrum of a star that is occulting behind the Earth's atmosphere. The prime contractor of GOMOS is Matra Marconi Space France. The focal plane optics are designed and manufactured by Spacebel Instrumentation S.A. and the holographic grating by Jobin-Yvon. VTT Automation, Measurement Technology has participated in the GOMOS studies since 1989 and is presently responsible for the verification tests of the imaging quality and opto-mechanical interfaces of the holographic imaging grating of GOMOS. The UVIS spectrometer of GOMOS consists of a holographic, aberration corrected grating and of a CCD detector. The alignment of the holographic grating needs as an input very accurate knowledge of the mechanical interfaces. VTT Automation has designed, built and tested a characterization system for the holographic grating. This system combines the accurate optical imaging measurements with the absolute knowledge of the geometrical parameters at the accuracy of plus or minus 10 micrometers which makes the system unique. The developed system has been used for two breadboard gratings and the qualification model grating. The imaging quality results and their analysis together with alignment procedure utilizing of the knowledge of mechanical interfaces is described.
- Published
- 1996
- Full Text
- View/download PDF
322. Do coronary bypass graft flows differ between on-pump and off-pump operations?
- Author
-
UCL - MD/CHIR - Département de chirurgie, UCL - (MGD) Unité de support scientifique, Louagie, Yves, Jamart, Jacques, Gruslin, André, UCL - MD/CHIR - Département de chirurgie, UCL - (MGD) Unité de support scientifique, Louagie, Yves, Jamart, Jacques, and Gruslin, André
- Abstract
BACKGROUND: The aim of this study is to compare hemodynamic factors in coronary bypass grafts on-pump and off-pump. METHODS: Two propensity score-matched groups of 89 patients each including 408 dual beam Doppler flow measurements were compared. The study included only patent and single terminolateral bypass grafts. RESULTS: Flow was 64.9 +/- 37.3 mL/min in the on-pump group versus 58.6 +/- 35.0 mL/min in the off-pump group (p = 0.063); velocity was 23.8 +/- 10.5 versus 20.5 +/- 10.4 cm/s (p = 0.004); resistance measured as mm Hg/(mL/min(-1)) was 1.50 +/- 1.09 versus 1.76 +/- 1.14 (p = 0.020); pulsatility index was 1.98 +/- 1.52 versus 2.44 +/- 1.62 (p = 0.004). The hematocrit was 23.5 +/- 3.8% in the on-pump and 32.9 +/- 4.1% in the off-pump groups (p < 0 0.001). Multivariate analysis showed that hematocrit was the most significant factor influencing flow (p < 0.001) and velocity (p < 0.001), along with resistance (p = 0.004) and pulsatility index (p < 0.001). In a subset of 50 hemodynamic measurements made on left internal thoracic arteries implanted onto left anterior descending arteries and matched for hematocrit, there were no differences between on-pump and off-pump groups regarding flow, velocity, resistance, or pulsatility index. CONCLUSIONS: Off-pump compared with on-pump bypass surgery is associated with lower velocity and higher resistance in the grafts, mainly caused by changes in hematocrit and viscosity related to hemodilution.
- Published
- 2005
323. P32.09: Sonography cervical surveillance with ultrasound-indicated cervical cerclage as compared to prophylatic cerclage in pregnants with clinical risk factors for preterm birth
- Author
-
Moretti, F. M., primary, Al Jishi, T., additional, and Gruslin, A., additional
- Published
- 2012
- Full Text
- View/download PDF
324. 009 Elevated Serum PCSK9 in Normal Third Trimester Pregnancy, Pre-Eclampsia and Intrauterine Growth Restriction
- Author
-
Peticca, P., primary, Gruslin, A., additional, Cousins, M., additional, Adetola, E., additional, Mayne, J., additional, and Ooi, T., additional
- Published
- 2012
- Full Text
- View/download PDF
325. An active pregnancy for fetal well-being? The value of active living for most women and their babies
- Author
-
Ferraro, Zachary M, primary, Gruslin, Andree, additional, and Adamo, Kristi B, additional
- Published
- 2012
- Full Text
- View/download PDF
326. In Vitro Regulatory Effect of Epididymal Serpin CRES on Protease Activity of Proprotein Convertase PC4/PCSK4
- Author
-
Mishra, P., primary, Qiu, Q., additional, Gruslin, A., additional, Hidaka, Y., additional, Mbikay, M., additional, and Basak, A., additional
- Published
- 2012
- Full Text
- View/download PDF
327. Significance of IGFBP-4 in the Development of Fetal Growth Restriction
- Author
-
Qiu, Qing, primary, Bell, Mike, additional, Lu, Xiaoyin, additional, Yan, Xiaojuan, additional, Rodger, Marc, additional, Walker, Mark, additional, Wen, Shi-Wu, additional, Bainbridge, Shannon, additional, Wang, Hongmei, additional, and Gruslin, Andree, additional
- Published
- 2012
- Full Text
- View/download PDF
328. Characterization of the insulin-like growth factor axis in term pregnancies complicated by maternal obesity
- Author
-
Ferraro, Z. M., primary, Qiu, Q., additional, Gruslin, A., additional, and Adamo, K. B., additional
- Published
- 2012
- Full Text
- View/download PDF
329. Adverse Fetal and Neonatal Outcomes Associated with a Life-Long High Fat Diet: Role of Altered Development of the Placental Vasculature
- Author
-
Hayes, Emily K., primary, Lechowicz, Anna, additional, Petrik, Jim J., additional, Storozhuk, Yaryna, additional, Paez-Parent, Sabrina, additional, Dai, Qin, additional, Samjoo, Imtiaz A., additional, Mansell, Margaret, additional, Gruslin, Andree, additional, Holloway, Alison C., additional, and Raha, Sandeep, additional
- Published
- 2012
- Full Text
- View/download PDF
330. Prediction of Adverse Maternal Outcomes in Preeclampsia
- Author
-
von Dadelszen, P., primary, Payne, B., additional, Li, J., additional, Ansermino, J.M., additional, Broughton Pipkin, F., additional, Côté, A.M., additional, Douglas, M.J., additional, Gruslin, A., additional, Hutcheon, J.A., additional, Joseph, K.S., additional, Kyle, P.M., additional, Lee, T., additional, Loughna, P., additional, Menzies, J.M., additional, Merialdi, M., additional, Millman, A.L., additional, Moore, M.P., additional, Moutquin, J.M., additional, Ouellet, A.B., additional, Smith, G.N., additional, Walker, J.J., additional, Walley, K.R., additional, Walters, B.N., additional, Widmer, M., additional, Lee, S.K., additional, Russell, J.A., additional, and Magee, L.A., additional
- Published
- 2012
- Full Text
- View/download PDF
331. Reversed umbilical arterial end diastolic flow, sildenafil treatment and early stillbirths
- Author
-
von Dadelszen, P, primary, Lim, KI, additional, Dwinnell, S, additional, Magee, LA, additional, Carleton, BC, additional, Gruslin, A, additional, Lee, B, additional, Liston, RM, additional, Miller, SP, additional, Rurak, D, additional, Sherlock, RL, additional, Skoll, MA, additional, Wareing, MM, additional, and Baker, PN, additional
- Published
- 2012
- Full Text
- View/download PDF
332. Human Amniotic Fluid Cells Form Functional Gap Junctions with Cortical Cells
- Author
-
Jezierski, Anna, primary, Rennie, Kerry, additional, Tremblay, Roger, additional, Zurakowski, Bogdan, additional, Gruslin, Andreé, additional, Sikorska, Marianna, additional, and Bani-Yaghoub, Mahmud, additional
- Published
- 2012
- Full Text
- View/download PDF
333. 389: Placental biometry and intraplacental villous artery Doppler as predictors of placentally-mediated pregnancy complications
- Author
-
Mayer, Chantal, primary, Gruslin, Andree, additional, Guan, Camila, additional, von Daldelszen, Peter, additional, and Butler, Blair, additional
- Published
- 2012
- Full Text
- View/download PDF
334. Applications of Amniotic Membrane and Fluid in Stem Cell Biology and Regenerative Medicine
- Author
-
Rennie, Kerry, primary, Gruslin, Andrée, additional, Hengstschläger, Markus, additional, Pei, Duanqing, additional, Cai, Jinglei, additional, Nikaido, Toshio, additional, and Bani-Yaghoub, Mahmud, additional
- Published
- 2012
- Full Text
- View/download PDF
335. Continuous cold blood cardioplegia improves myocardial protection: a prospective randomized study.
- Author
-
UCL - MD/CHIR - Département de chirurgie, UCL - MD/MINT - Département de médecine interne, UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique, Louagie, Yves, Jamart, Jacques, Gonzalez, Manuel, Collard, Edith, Broka, Serge, Galanti, Laurence, Gruslin, André, UCL - MD/CHIR - Département de chirurgie, UCL - MD/MINT - Département de médecine interne, UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique, Louagie, Yves, Jamart, Jacques, Gonzalez, Manuel, Collard, Edith, Broka, Serge, Galanti, Laurence, and Gruslin, André
- Abstract
BACKGROUND: To assess the influence on myocardial protection of the rate of infusion (continuous vs intermittent) of cold blood cardioplegia administered retrogradely during prolonged aortic cross-clamping. The end-points were ventricular performance and biochemical markers of ischemia. METHODS: Seventy patients undergoing myocardial revascularization for three-vessel disease were prospectively randomized to receive intermittent or continuous retrograde cold blood cardioplegia. Hemodynamic measurements were obtained using a rapid-response thermodilution catheter and included right ventricular ejection fraction, cardiac output, left and right ventricular stroke work index, and systemic and pulmonary vascular resistance. Blood samples were obtained from the coronary sinus before cross-clamp application and immediately after cross-clamp removal for determinations of lactate and hypoxanthine. RESULTS: The left ventricular stroke work index trend was significantly superior (p = 0.038) by repeated-measures analysis in continuous cardioplegia. Other hemodynamic measurements revealed a similar trend. The need for postoperative inotropic drugs support was reduced in continuous cardioplegia. The release of lactate in the coronary sinus after unclamping was 2.30 +/- 0.12 mmol/L after intermittent cardioplegia and 1.97 +/- 0.09 mmol/L after continuous cardioplegia (p = 0.036). The release of hypoxanthine was 20.47 +/- 2.74 micromol/L in intermittent cardioplegia and 11.77 +/- 0.69 micromol/L in continuous cardioplegia (p = 0.002). CONCLUSIONS: Continuous cold blood cardioplegia results in improved ventricular performance and reduced myocardial ischemia in comparison with intermittent administration.
- Published
- 2004
336. Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report
- Author
-
Abdulghani, Sahar, Moretti, Felipe, Gruslin, Andree, and Grynspan, David
- Abstract
Massive perivillous fibrin deposition (MPVFD) and chronic intervillositis (CI) are related rare pathological correlates of severe intrauterine growth restriction (IUGR) and fetal loss with high recurrence rates. No standard management has been established.
- Published
- 2017
- Full Text
- View/download PDF
337. No. 96-The Reproductive Care of Women Living With Hepatitis C Infection
- Author
-
Boucher, Marc and Gruslin, Andrée
- Abstract
hepatitis C virus (HCV) is an increasingly important public health problem worldwide. Health care workers providing care to women of childbearing age are uniquely placed in their practices to identify a significant proportion of at-risk patients and to provide appropriate screening and counselling. The primary objective of this guideline is to provide accurate, current information to those offering reproductive care to women living with HCV. This document is also intended to raise awareness of HCV in both the medical and general populations.
- Published
- 2017
- Full Text
- View/download PDF
338. No96-Sur les soins de santé en reproduction pour les femmes vivant avec l'hépatite C
- Author
-
Boucher, Marc and Gruslin, Andrée
- Abstract
le virus de l'hépatite C (VHC) pose une menace de plus en plus sérieuse à la santé publique à l'échelle mondiale. Les travailleurs de la santé qui s'occupent des femmes en âge de procréer sont particulièrement bien placés pour identifier un nombre important de femmes à risque et fournir les services de dépistage et de counseling appropriés. Le principal objectif de ces lignes directrices est de fournir une information exacte et à jour à tous ceux et celles qui prodiguent des soins de santé en reproduction aux femmes vivant avec le VHC. Ce document vise aussi à sensibiliser le monde médical et le grand public au problème de l'hépatite C.
- Published
- 2017
- Full Text
- View/download PDF
339. Pre-eclampsia: Fetal assessment and neonatal outcomes
- Author
-
Gruslin, Andrée, primary and Lemyre, Brigitte, additional
- Published
- 2011
- Full Text
- View/download PDF
340. Characterization and role of NUMB in the human extravillous trophopblast
- Author
-
Haider, M., primary, Qiu, Q., additional, Bani-Yaghoub, M., additional, Tsang, B.K., additional, and Gruslin, A., additional
- Published
- 2011
- Full Text
- View/download PDF
341. Prediction of Adverse Maternal Outcomes in Preeclampsia: Development and Validation of the FullPIERS Model
- Author
-
von Dadelszen, Peter, primary, Payne, Beth, additional, Li, Jing, additional, Ansermino, J. Mark, additional, Broughton Pipkin, Fiona, additional, Côté, Anne-Marie, additional, Douglas, M. Joanne, additional, Gruslin, Andrée, additional, Hutcheon, Jennifer A., additional, Joseph, K. S., additional, Kyle, Phillipa M., additional, Lee, Tang, additional, Loughna, Pamela, additional, Menzies, Jennifer M., additional, Merialdi, Mario, additional, Millman, Alexandra L., additional, Moore, M. Peter, additional, Moutquin, Jean-Marie, additional, Ouellet, Annie B., additional, Smith, Graeme N., additional, Walker, James J., additional, Walley, Keith R., additional, Walters, Barry N., additional, Widmer, Mariana, additional, Lee, Shoo K., additional, Russell, James A., additional, and Magee, Laura A., additional
- Published
- 2011
- Full Text
- View/download PDF
342. Weight in Pregnancy and Its Implications: What Women Report
- Author
-
Gaudet, Laura M., primary, Gruslin, Andrée, additional, and Magee, Laura A., additional
- Published
- 2011
- Full Text
- View/download PDF
343. 434: Sildenafil citrate therapy for early-onset severe intrauterine growth restriction
- Author
-
Dwinnell, Shannon, primary, Magee, Laura, additional, Lim, Kenneth, additional, Liston, Robert, additional, Miller, Steven, additional, Payne, Beth, additional, Rurak, Dan, additional, Sherlock, Rebecca, additional, Skoll, M. Amanda, additional, Wareing, Mark, additional, Baker, Philip, additional, von Dadelszen, Peter, additional, Gruslin, Andree, additional, Carleton, Bruce, additional, and Lee, Benny, additional
- Published
- 2011
- Full Text
- View/download PDF
344. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model
- Author
-
von Dadelszen, Peter, primary, Payne, Beth, additional, Li, Jing, additional, Ansermino, J Mark, additional, Pipkin, Fiona Broughton, additional, Côté, Anne-Marie, additional, Douglas, M Joanne, additional, Gruslin, Andrée, additional, Hutcheon, Jennifer A, additional, Joseph, KS, additional, Kyle, Phillipa M, additional, Lee, Tang, additional, Loughna, Pamela, additional, Menzies, Jennifer M, additional, Merialdi, Mario, additional, Millman, Alexandra L, additional, Moore, M Peter, additional, Moutquin, Jean-Marie, additional, Ouellet, Annie B, additional, Smith, Graeme N, additional, Walker, James J, additional, Walley, Keith R, additional, Walters, Barry N, additional, Widmer, Mariana, additional, Lee, Shoo K, additional, Russell, James A, additional, and Magee, Laura A, additional
- Published
- 2011
- Full Text
- View/download PDF
345. P32.09: Sonography cervical surveillance with ultrasound-indicated cervical cerclage as compared to prophylatic cerclage in pregnants with clinical risk factors for preterm birth
- Author
-
A. Gruslin, T. Al Jishi, and F. M. Moretti
- Subjects
Gynecology ,medicine.medical_specialty ,education.field_of_study ,Radiological and Ultrasound Technology ,Singleton ,business.industry ,Obstetrics ,medicine.medical_treatment ,Ultrasound ,Population ,MEDLINE ,Obstetrics and Gynecology ,General Medicine ,law.invention ,medicine.anatomical_structure ,Reproductive Medicine ,Randomized controlled trial ,law ,medicine ,Gestation ,Radiology, Nuclear Medicine and imaging ,Cervical cerclage ,business ,education ,Cervix - Abstract
Objectives: To evaluate comparatively two management modalities in women with singleton pregnancies and with clinical risk factors for PTB (based on obstetric and gynecologic history): transvaginal ultrasound (TVU) surveillance of the cervical length and placement of CC indicated by cervical shortening (therapeutic cerclage, TC) versus prophylactic (elective) cerclage (PC). Methods: Data Sources and Study Selection: A search of entries in electronic databases (MEDLINE, EMBASE) was supplemented with references cited in original articles to identify randomized trials and case-control studies comparing pregnancy outcomes after cervical surveillance and TC versus PC in a high-risk population of pregnant women with singleton pregnancies. Case and control groups consisted of women with singleton pregnancies matched for obstetrical and gynecological risk factors for preterm birth. The outcomes assessed were preterm delivery before 35 weeks or prior to 24 weeks of gestation. Studies were excluded if there was no matched control group or if only the abstract was available. Results: Of 5 studies identified, 3 met the inclusion criteria. A total of 367 patients were evaluated, 215 in the cervical surveillance arm and 152 with PC. Compared to women with PC, those who were followed by cervical surveillance, had no increased risk of preterm delivery before 24 or 35 weeks, respectively (RR 1.41; 95%CI 0.58–3.41; RR 1.24; 95%CI 0.75–2.04, respectively). The conservative approach achieved a 62% reduction in the number of patients undergoing CC placement. Conclusions: Serial TVU of the cervix with ultrasound-indicated TC appears a safe alternative to traditional PC and it spares a significant number of pregnant women an intervention with potential inherent complications.
- Published
- 2012
- Full Text
- View/download PDF
346. 009 Elevated Serum PCSK9 in Normal Third Trimester Pregnancy, Pre-Eclampsia and Intrauterine Growth Restriction
- Author
-
Teik Chye Ooi, M. Cousins, A. Gruslin, E. Adetola, J. Mayne, and P. Peticca
- Subjects
Elevated serum ,medicine.medical_specialty ,Eclampsia ,Obstetrics ,business.industry ,Third Trimester Pregnancy ,PCSK9 ,medicine ,Intrauterine growth restriction ,Cardiology and Cardiovascular Medicine ,medicine.disease ,business - Published
- 2012
- Full Text
- View/download PDF
347. Adverse Fetal and Neonatal Outcomes Associated with a Life-Long High Fat Diet: Role of Altered Development of the Placental Vasculature
- Author
-
Andrée Gruslin, Anna Lechowicz, Alison C. Holloway, Emily K. Hayes, Jim Petrik, Sabrina Paez-Parent, Imtiaz A. Samjoo, Yaryna Storozhuk, Margaret Mansell, Sandeep Raha, and Qin Dai
- Subjects
Leptin ,Anatomy and Physiology ,Calorie ,Placenta ,lcsh:Medicine ,Adipose tissue ,Pediatrics ,Rats, Sprague-Dawley ,0302 clinical medicine ,Pregnancy ,Hypoxia ,lcsh:Science ,2. Zero hunger ,0303 health sciences ,030219 obstetrics & reproductive medicine ,Multidisciplinary ,Obstetrics and Gynecology ,Animal Models ,3. Good health ,medicine.anatomical_structure ,Adipose Tissue ,Medicine ,Gestation ,Female ,Research Article ,medicine.medical_specialty ,Biology ,03 medical and health sciences ,Fetus ,Model Organisms ,Internal medicine ,medicine ,Animals ,Humans ,Obesity ,Fetal Death ,Triglycerides ,Nutrition ,030304 developmental biology ,lcsh:R ,Reproductive System ,medicine.disease ,Dietary Fats ,Rats ,Disease Models, Animal ,Endocrinology ,Women's Health ,lcsh:Q - Abstract
Maternal obesity results in a number of obstetrical and fetal complications with both immediate and long-term consequences. The increased prevalence of obesity has resulted in increasing numbers of women of reproductive age in this high-risk group. Since many of these obese women have been subjected to hypercaloric diets from early childhood we have developed a rodent model of life-long maternal obesity to more clearly understand the mechanisms that contribute to adverse pregnancy outcomes in obese women. Female Sprague Dawley rats were fed a control diet (CON - 16% of calories from fat) or high fat diet (HF - 45% of calories from fat) from 3 to 19 weeks of age. Prior to pregnancy HF-fed dams exhibited significant increases in body fat, serum leptin and triglycerides. A subset of dams was sacrificed at gestational day 15 to evaluate fetal and placental development. The remaining animals were allowed to deliver normally. HF-fed dams exhibited a more than 3-fold increase in fetal death and decreased neonatal survival. These outcomes were associated with altered vascular development in the placenta, as well as increased hypoxia in the labyrinth. We propose that the altered placental vasculature may result in reduced oxygenation of the fetal tissues contributing to premature demise and poor neonatal survival.
- Published
- 2012
- Full Text
- View/download PDF
348. Reversed umbilical arterial end diastolic flow, sildenafil treatment and early stillbirths
- Author
-
S Dwinnell, Mark Wareing, Steven P. Miller, L A Magee, P. von Dadelszen, Bruce Carleton, Benny Lee, K. Lim, Dan W. Rurak, Robert M. Liston, MA Skoll, Philip N. Baker, Rebecca Sherlock, and Andrée Gruslin
- Subjects
chemistry.chemical_compound ,chemistry ,Sildenafil ,business.industry ,Anesthesia ,Obstetrics and Gynecology ,Medicine ,business ,Diastolic flow - Published
- 2012
- Full Text
- View/download PDF
349. 389: Placental biometry and intraplacental villous artery Doppler as predictors of placentally-mediated pregnancy complications
- Author
-
Chantal Mayer, Camila Guan, Peter von Daldelszen, Blair Butler, and Andrée Gruslin
- Subjects
education.field_of_study ,Pregnancy ,medicine.medical_specialty ,business.industry ,Obstetrics ,Birth weight ,Population ,Obstetrics and Gynecology ,Gestational age ,medicine.disease ,Preeclampsia ,Obstetrics and gynaecology ,medicine ,Risk factor ,education ,business ,Cohort study - Abstract
artery Doppler as predictors of placentallymediated pregnancy complications Chantal Mayer, Andree Gruslin, Camila Guan, Peter von Daldelszen, Blair Butler University of British Columbia, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Vancouver, BC, Canada, University of Ottawa, Ottawa Hospital Research Institute, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Ottawa, ON, Canada OBJECTIVE: Pre-eclampsia(PE) and fetal growth restriction are late complications though abnormal placental perfusion is present from implantation. Umbilical artery (UA) Doppler does not provide early diagnosis as significant changes in the waveform do not appear until late in the process. Assessment of the intraplacental villous arteries (IPVA) is proposed to provide earlier diagnosis by detecting subtle early changes in the placental microvasculature. Preliminary results suggested a significant correlation between IPVA pulsatility index (PI) performed at 20, 28, 34 weeks gestational age (GA) and birth weight. The placenta of the fetus with impaired perfusion is also smaller than average. Preliminary data demonstrated a correlation between second trimester maximal placental length (MPL), thickness (MPT) and birth weight (BW). We sought to reproduce these results in a high risk population and hypothesized that both IPVA Doppler and placental biometry are predictive of a combined outcome of placentally-mediated complications. STUDY DESIGN: Patients with at least 1 risk factor for PE were recruited. Placental sonograms for biometry and IPVA Doppler were performed at 17-24 weeks and at 28-32 weeks GA. The Mann-Whitney test was used to correlate candidate predictors to the combined outcome. RESULTS: Seventy-three patients were recruited. Composite primary outcome consisting of BW 10%ile, PE, abruption, stillbirth, neonatal death, umbilical cord pH 7.0 or BE to 12mmo/l occurred in 16 (21.9%). Second trimester placental biometry and IPVA Doppler were not found to be significantly predictive of the primary outcome: MPL [p 0.61]; MPT [p 0.91]; IPVA PI [p 0.25]. Thirty-five patients underwent a third trimester examination, 7 of which had the composite outcome (20%). Third trimester placental biometry was not found to be predictive of outcome (MPL [p 0.49], MPT [p 0.12]),but IPVA PI was [p 0.03]. CONCLUSION: In a high risk population, second trimester placental biometry and IPVA Doppler were not predictive of a composite outcome of placentally-mediated complications but third trimester IPVA PI was. 390 The added value of second trimester uterine artery Doppler in the identification of nulliparous women at increased risk for preeclampsia: an individual patient data metaanalysis Emily Kleinrouweler, Patrick Bossuyt, Joris van der Post, Javier Arenas, Koen Deurloo, Abdalla Diab, Maureen Macleod, Akihide Ohkuchi, Basky Thilaganathan, Karlijn Vollebregt, Hans Wolf, Ben Mol, Eva Pajkrt Academic Medical Center, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands, Academic Medical Center, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam, Netherlands, Hospital de Cabuenes, Department of Obstetrics and Gynaecology, Gijon, Spain, Free University Medical Center, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands, Zagazig Faculty of Medicine, Department of Obstetrics and Gynaecology, Zagazig, Egypt, University of Dundee, Ninewells Hospital & Medical School, Department of Obstetrics and Gynaecology, Dundee, United Kingdom, Jichi Medical University School of Medicine, Department of Obstetrics and Gynecology, Tochigi, Japan, St Georges Hospital, Department of Obstetrics and Gynaecology, London, United Kingdom OBJECTIVE: Pre-eclampsia is a major obstetric problem. Screening pregnant women to identify those at risk of developing pre-eclampsia could substantially improve quality and focus of antenatal care, and thereby maternal and perinatal outcomes. We investigated the added value of second trimester uterine artery Doppler to patient characteristics in the identification of nulliparous women at risk for pre-eclampsia using individual patient data from previous studies. STUDY DESIGN: We performed a meta-analysis with individual patient data of cohort studies. We searched Medline and Embase to identify eligible articles. Datasets in which patient characteristics, second trimester Doppler ultrasound findings, and the occurrence of pre-eclampsia were available in nulliparous women were included. Authors were invited to share their original datasets. Shared data were checked for consistency, recoded to acquire uniformity, and merged into one dataset. Logistic regression models with a random intercept for study number were constructed for each of the patient and Doppler characteristics alone and in combinations. Performance of models was compared by the likelihood statistic. Discrimination of the models was assessed using the area under the ROC curve (AUC). RESULTS: Eight datasets containing 6708 nulliparous women were used, of which 302 (4.5%) developed pre-eclampsia. Doppler findings included higher, lower and mean Pulsatility Index (PI) and Resistance Index (RI), and any or bilateral notching. Of these, the best predictors were combinations of mean PI or RI and bilateral notching (AUC 0.676 [95% CI 0.618-0.734] and 0.688 [0.650-0.725]). Addition of patient characteristics BMI or blood pressure increased model performance (model with BMI, PI and notching: AUC 0.734 [0.682-0.785], model with BMI, RI and notching: 0.762 [0.725-0.799]). CONCLUSION: The addition of Doppler characteristics mean PI or RI and bilateral notching to patient characteristics blood pressure or BMI improves the identification of women at risk for pre-eclampsia. The combined model performes better than patient or Doppler characteristics alone. Poster Session III Doppler Assessment, Fetus, Prematurity www.AJOG.org
- Published
- 2012
- Full Text
- View/download PDF
350. [59-OR]: The control of hypertension in pregnancy study (CHIPS) randomized controlled trial – Is the type of antihypertensive important?
- Author
-
Magee, Laura A., Dadelszen, Peter von, Rey, Evelyne, Ross, Susan, Asztalos, Elizabeth, Murphy, Kellie E., Menzies, Jennifer, Sanchez, Johanna, Singer, Joel, Gafni, Amiram, Gruslin, Andree, Helewa, Michael, Hutton, Eileen, Lee, Shoo K., Logan, Alexander G., Ganzevoort, Wessel, Welch, Ross, Thornton, Jim G., and Moutquin, Jean-Marie
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.